260 results on '"Gil-Vernet, S"'
Search Results
2. Long-Term Results of Biopsy-Guided Selection and Allocation of Kidneys From Older Donors in Older Recipients
3. Longterm allograft outcome in patients treated with prophylactic antilymphocyte globulin or OKT3 as induction therapy in cadaveric kidney transplantation
4. Evaluation of biopsy changes in the early diagnosis of chronic transplant nephropathy
5. Ischemia—reperfusion injury as a risk factor for late kidney graft failure
6. Assessing the Limits in Kidney Transplantation: Use of Extremely Elderly Donors and Outcomes in Elderly Recipients
7. Renal Function in Patients With Cadaveric Kidney Transplants Treated With Tacrolimus or Cyclosporine
8. Gastrointestinal Complications in Renal Transplant Recipients: MITOS Study
9. Donor Structural and Functional Parameters Are Independent Predictors of Renal Function at 3 Months
10. Successful Treatment of Chronic HCV Infection Should Not Preclude Kidney Donation to an HCV Negative Recipient
11. Renal Function at Six Months Is the Most Relevant Risk Factor for Graft Failure at Seven Years after Renal Transplantation.: Abstract# 1582: Poster Board #-Session: P144-IV
12. Biopsy-Guided Selection and Allocation of Kidneys from Older Donors in Older Recipients.: Abstract# 122
13. Sequential treatment of cytomegalovirus infection or disease with a short course of intravenous ganciclovir followed by oral valganciclovir: efficacy, safety, and pharmacokinetics
14. Clinical features and outcomes of Legionnairesʼ disease in solid organ transplant recipients
15. Arterial Elasticity Measurement in Renal Transplant Patients Under Anticalcineurin Immunosuppression
16. Long-Term Effect of Hepatitis C Virus Chronic Infection on Patient and Renal Graft Survival
17. Therapy With Plasmapheresis and Intravenous Immunoglobulin for Acute Humoral Rejection in Kidney Transplantation
18. Clinical and Virological Effects During Two Years of Ongoing Adefovir Dipivoxil in the Treatment of Lamivudine-Resistant Chronic Hepatitis B Infection
19. Immunosuppression for Dual Kidney Transplantation with Marginal Organs: The Old Is Better Yet
20. Subclinical Rejection Associated with Chronic Allograft Nephropathy in Protocol Biopsies as a Risk Factor for Late Graft Loss
21. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome
22. Influence of hematopoietic microchimerism in organ tolerance after kidney or heart transplantation
23. Histologic findings in protocol biopsies performed in stable renal allografts under different immunosuppressive schedules
24. «De Novo» Carcinoma after Liver Transplant (L.T.)
25. HCV Chronic Infection in HD (Hemodialysed) Candidates to KT (Kidney Transplant). Influence of Virus C Genotypes on Response to IFN Treatment
26. The use of azithromycin for cyclosporin-induced gingival overgrowth
27. Lipid-lowering long-term effects of six different statins in hypercholesterolemic renal transplant patients under cyclosporine immunosuppression
28. TGF-β1 gene expression in protocol biopsies from patients with stable renal allograft function
29. Kidneys from Maastricht category III: Does NECMO influence on DGF?
30. Origen y desarrollo de la Tuberculosis genital masculina
31. Renal Failure Due to Diuretics
32. PT029 - Kidneys from Maastricht category III: Does NECMO influence on DGF?
33. Total glomerular number in stable renal allografts
34. Predictive value of cyclosporine blood levels during the absorption phase to estimate the area under the curve in stable renal transplant patients
35. Arterial intimal thickening in stable renal allografts during the first year of follow-up
36. Risk factors for graft loss and mortality after renal transplantation according to recipient age: a prospective multicentre study
37. Pretransplant Diabetes Mellitus Doubles the Risk of Cardiovascular Events after Renal Transplantation. A Prospective Multicenter Study
38. Renal Function at Six Months Is the Most Relevant Risk Factor for Graft Failure at Seven Years after Renal Transplantation
39. Multivariate analysis of prognostic factors in renal transplantation
40. Sequential treatment of cytomegalovirus infection or disease with a short course of intravenous ganciclovir followed by oral valganciclovir: efficacy, safety, and pharmacokinetics
41. Population Pharmacokinetics of Ganciclovir after Intravenous Ganciclovir and Oral Valganciclovir Administration in Solid Organ Transplant Patients Infected with Cytomegalovirus
42. POPULATION PHARMACOKINETICS OF VALGANCICLOVIR IN SOLID ORGAN TRANSPLANT RECIPIENTS INFECTED BY CYTOMEGALOVIRUS
43. Prophylactic OKT3, CyA, and steroids versus antilymphoblast globulin, CyA, and steroids in cadaveric kidney transplantation
44. Early and late steroid withdrawal from cyclosporine and mycophenolate mofetil are achievable: steroids can be safely withdrawn from cyclosporine and mycophenolate mofetil-treated renal allograft recipients: long-term results
45. [Antilymphocyte serum, cyclosporine and corticoids, versus OKT3, cyclosporine, and corticoids in kidney transplantation]
46. Renal Transplantation (RT) in Diabetic Nephropathy (DN) in the 80’s Decade
47. Posttransplant Diabetes Mellitus in Renal Allograft Recipients: A Prospective Multicenter Study at 2 Years
48. Double kidney transplantation: the importance of the maintenance of possible donors of marginal kidneys
49. Mycophenolate mofetil overlap in liver transplant recipients with chronic cyclosporine nephrotoxicity
50. Double kidney transplant
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.